EXCLUSIVE LICENSE AGREEMENT between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and NOCIMED, LLC for SYSTEMS, MATERIALS, AND METHODS TO LOCALIZE AND EVALUATE PAIN AND DEGENERATIVE PROPERTIES OF TISSUE UC Case Nos. SF2005-063, SF2005-064, SF2006-113...Exclusive License Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software • California
This license agreement ("Agreement") is made effective this 18th day of January, 2008 ("Effective Date"), by and between The Regents of the University of California ("The Regents"), a California corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 and acting through its Office of Technology Management, University of California San Francisco, 185 Berry Street, Suite 4603, San Francisco, California 94107, and Nocimed, LLC ("Licensee"), a Delaware limited liability corporation, having a principal place of business at 713 Sandoval Way, Hayward, California 94544.
SUBORDINATED CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software • California
This Subordinated Convertible Promissory Note and Warrant Purchase Agreement (this “ Agreement”) is made as of February 28, 2020 by and between Nocimed, Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
FIRST AMENDMENT TO RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTSale Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software
This FIRST AMENDMENT TO AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (the “Amendment”) is dated and effective as of February 28, 2020 (the “Amendment Date”), by and among NOCIMED, INC., a Delaware corporation (the “Company”), and the parties set forth on the signature pages hereto. Capitalized terms used but not defined herein shall have the meanings assigned to them in the Co-Sale Agreement (as defined below).
SERIES B PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software • Delaware
THIS SERIES B PREFERRED STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of February 18, 2015, by and among NOCIMED, INC., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, whose names are set forth on the Schedule of Purchasers attached hereto as Schedule A (which persons and entities are hereinafter collectively referred to as “Purchasers” and each individually as a “Purchaser”).
Strategic Collaboration Agreement for Phased Commercialization of the Siemens- compatible NOCISCAN-LS Product of Nocimed, Inc.Strategic Collaboration Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software
WHEREAS, Nocimed has CE Marked its NOCISCAN-LS product that is supported by a Clinical Evaluation Report (CER) from a prior clinical study conducted by Nocimed for identifying painful lumbar spinal discs, and for predicting successful discogenic low back pain surgery outcomes.
